Lista de obras -

A Decision Analysis Evaluating Screening for Kidney Cancer Using Focused Renal Ultrasound

scientific article published on 14 September 2019

Assessment of quality of life using Skindex-16 in patients with advanced basal cell carcinoma treated with vismodegib in the STEVIE study

scientific article published on 01 December 2018

Augmenting the randomized controlled trial with real-world data to aid clinical decision making in metastatic renal cell carcinoma: a systematic review and meta-analysis

artículo científico publicado en 2019

British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020

artículo científico publicado en 2020

British HIV Association guidelines for HIV-associated malignancies 2014.

artículo científico publicado en 2014

Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma.

scientific article published on 10 August 2016

Current management of AIDS related non Hodgkin’s lymphoma

article

Dose escalation of axitinib on disease progression as a strategy in the treatment of metastatic renal cell carcinoma

artículo científico publicado en 2018

Evolving treatment options for melanoma brain metastases

artículo científico

External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma

artículo científico publicado en 2018

Hedgehog pathway inhibitors come of age

artículo científico publicado en 2019

Improving clinical trial recruitment: experience of a tertiary renal oncology centre

artículo científico publicado en 2013

Localized Porokeratosis Secondary to Ionizing Radiotherapy for Prostate Carcinoma ⬇️

artículo científico publicado el 1 de noviembre de 2010

Management of melanoma

artículo científico

Managing adverse events associated with vismodegib in the treatment of basal cell carcinoma

artículo científico publicado en 2016

Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group study ⬇️

artículo científico publicado en 2017

Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial.

artículo científico publicado en 2014

Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR).

artículo científico publicado en 2017

PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma

artículo científico publicado en 2019

Pazopanib for the treatment of renal cell carcinoma

artículo científico

Pazopanib versus sunitinib in metastatic renal-cell carcinoma

artículo científico publicado en 2013

Prognostic effect of cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma: a comparative study using inverse probability of treatment weighting

artículo científico publicado en 2017

Radiological Response Heterogeneity Is of Prognostic Significance in Metastatic Renal Cell Carcinoma Treated with Vascular Endothelial Growth Factor-targeted Therapy

scientific article published on 06 February 2019

Radiosensitization of vinorelbine and gemcitabine in NCI-H460 non-small-cell lung cancer cells

artículo científico publicado en 2004

Recent insights into the pathogenesis of Kaposi's sarcoma

artículo científico publicado en 1996

Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial.

artículo científico publicado en 2012

Selection of oncogenic mutant clones in normal human skin varies with body site

artículo científico publicado en 2020

Sunitinib for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis of Real-World and Clinical Trials Data

artículo científico publicado en 2019

The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohort

scientific article published on 03 October 2019

Treatment of succinate dehydrogenase B-associated renal cancer.

artículo científico publicado en 2017

Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK

artículo científico publicado en 2020

Vismodegib for Locally Advanced Periocular and Orbital Basal Cell Carcinoma: A Review of 15 Consecutive Cases

artículo científico publicado en 2017

Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial

artículo científico publicado en 2015

Lista de obras de

A Decision Analysis Evaluating Screening for Kidney Cancer Using Focused Renal Ultrasound

Assessment of quality of life using Skindex-16 in patients with advanced basal cell carcinoma treated with vismodegib in the STEVIE study

Augmenting the randomized controlled trial with real-world data to aid clinical decision making in metastatic renal cell carcinoma: a systematic review and meta-analysis

British Association of Dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020

British HIV Association guidelines for HIV-associated malignancies 2014.

Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma.

Current management of AIDS related non Hodgkin’s lymphoma

Dose escalation of axitinib on disease progression as a strategy in the treatment of metastatic renal cell carcinoma

Evolving treatment options for melanoma brain metastases

External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma

Hedgehog pathway inhibitors come of age

Improving clinical trial recruitment: experience of a tertiary renal oncology centre

Localized Porokeratosis Secondary to Ionizing Radiotherapy for Prostate Carcinoma ⬇️

Management of melanoma

Managing adverse events associated with vismodegib in the treatment of basal cell carcinoma

Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group study ⬇️

Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial.

Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR).

PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma

Pazopanib for the treatment of renal cell carcinoma

Pazopanib versus sunitinib in metastatic renal-cell carcinoma

Prognostic effect of cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma: a comparative study using inverse probability of treatment weighting

Radiological Response Heterogeneity Is of Prognostic Significance in Metastatic Renal Cell Carcinoma Treated with Vascular Endothelial Growth Factor-targeted Therapy

Radiosensitization of vinorelbine and gemcitabine in NCI-H460 non-small-cell lung cancer cells

Recent insights into the pathogenesis of Kaposi's sarcoma

Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial.

Selection of oncogenic mutant clones in normal human skin varies with body site

Sunitinib for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis of Real-World and Clinical Trials Data

The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohort

Treatment of succinate dehydrogenase B-associated renal cancer.

Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK

Vismodegib for Locally Advanced Periocular and Orbital Basal Cell Carcinoma: A Review of 15 Consecutive Cases

Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial